Paolo Marchetti

Pubblicazioni

Titolo Pubblicato in Anno
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice SUPPORTIVE CARE IN CANCER 2019
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients CLINICAL LUNG CANCER 2019
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach JOURNAL OF CLINICAL ONCOLOGY 2019
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study 2019
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours 2019
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib EXPERIMENTAL HEMATOLOGY & ONCOLOGY 2018
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice ANALYTICAL CELLULAR PATHOLOGY 2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway CANCER IMMUNOLOGY RESEARCH 2018
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma MEDICINE 2018
Hyperprogressive disease and early hypereosinophilia after anti-PD-1 treatment. a case report DRUG SAFETY - CASE REPORTS 2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival MEDICAL ONCOLOGY 2018
The microbiota impact. bacteria shaping immunity, disease and response to therapy TRANSLATIONAL CANCER RESEARCH 2018
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition MOLECULAR AND CLINICAL ONCOLOGY 2018
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one CANCER TREATMENT REVIEWS 2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? JOURNAL OF TRANSLATIONAL MEDICINE 2018
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines ONCOTARGET 2018
Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial JOURNAL OF CLINICAL ONCOLOGY 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study CANCER BIOLOGY & THERAPY 2018
Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme EUROPEAN JOURNAL OF CANCER 2018
Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: a case report MEDICINE 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma